Nanostics Inc. is a private Canadian company that develops and commercializes novel and noninvasive diagnostic tests. Its core technology, ClarityDX®, uses advanced machine learning algorithms to create a disease risk score that predicts the presence of diseases. ClarityDX is applicable to a wide range of cancers and other diseases. Nanostics’ lead product, ClarityDX Prostate®, is a test that improves the accuracy of detecting clinically significant prostate cancer. Go to https://www.nanosticsdx.com/clarity-dx-prostate/ to order ClarityDX Prostate today.
Company Details
- Employees
- 21
- Founded
- -
- Address
- Edmonton, Alberta, Ca
- in****@****sdx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nanosticsdx.com
- Keywords
- Precision Health, Aggressive prostate cancer, Extracellular vesicles, Machine learning, Microflow Cytometry, High accuracy, Noninvasive tests, Metastatic cancer, Improved patient care, Diagnostic tools, High sensitivity, Liquid biopsy, Clinical validation, NPV, AUC, Accurate results, Metastatic blockers, Biotechnology, AI-Powered Diagnostics, Prostate Cancer, Bladder Cancer.
- HQ
- Edmonton, Alberta
Nanostics Inc. Questions
Nanostics Inc.'s website is nanosticsdx.com
Nanostics Inc.'s LinkedIn profile is https://ca.linkedin.com/company/nanosticsdx
Nanostics Inc. has
21 employees.
View email and phone details for 21
employees at Nanostics Inc..
Nanostics Inc.'s industry is
Biotechnology Research
Nanostics Inc.'s top competitors are
Entos Pharmaceuticals,
True Angle,
Nanotess,
Northern Rna Inc.,
Bioalberta,
Providence Therapeutics,
Syantra Inc.,
Future Fields,
Nimble Science,
Pulsemedica.
Nanostics Inc.'s support email address is info@nanosticsdx.com
Nanostics Inc.'s categories are Biotechnology Research
Nanostics Inc.'s founding year is 2017
